Targeted Nanovector Systems for Niche Environments

The inventive concept adapts nanovector technology for specialized delivery of active substances in unique operational environments, such as high-security needs, disaster relief, extreme weather conditions, high-altitude environments, and high-radiation environments.

The original patent disclosed nanovectors for delivering active substances in the body, but these nanovectors may not be suitable for use in niche environments. The new inventive concept addresses this limitation by introducing specialized nanovector systems that can operate effectively in these unique environments, ensuring targeted delivery of active substances.

The inventive concept comprises nanovector systems featuring polysiloxane-based nanoparticles with mean diameters tailored for specific niche environments. For high-security needs, the nanoparticles are coated with a stealth layer to evade detection by security sensors. In disaster relief scenarios, the nanoparticles are complexed with a chelating agent obtained by grafting of DOTAGA onto the nanoparticle for targeted delivery of doxorubicin. In extreme weather conditions, the nanoparticles are bonded to a thermoresponsive polymer for controlled release of the active substance. In high-altitude environments, the nanoparticles are complexed with a chelating agent obtained by grafting of DOTAGA onto the nanoparticle for targeted delivery of active substances. In high-radiation environments, the nanoparticles are bonded to a radiation-resistant polymer for enhanced stability.

The new inventive concept introduces novel adaptations of nanovector technology for specialized delivery of active substances in niche environments, which are not obvious from the original patent. The inventive concept's novelty lies in its ability to tailor nanovector systems for specific operational environments, ensuring targeted delivery of active substances.

Alternative embodiments of the inventive concept could include modifying the nanoparticle's surface chemistry for enhanced biocompatibility, incorporating additional targeting moieties for improved specificity, or developing novel chelating agents for enhanced stability. Variations of the inventive concept could also include adapting the nanovector systems for use in other niche environments, such as space exploration or high-temperature industrial processes.

The inventive concept has significant commercial potential in the pharmaceutical, biotechnology, and healthcare industries, particularly in areas such as targeted cancer therapy, disaster relief, and extreme environment operations. The market for specialized nanovector systems is expected to grow as the need for targeted delivery of active substances in niche environments increases.